NCT01352689View on ClinicalTrials.gov

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Hypertension
Interventions
DRUG

CKD-828(FDC)

Drug: Telmisartan 80mg + S-Amlodipine 2.5mg(FDC) Tablet, Oral, Once Daily

DRUG

Combination Therapy

"Drug: Telmisatan 80mg Tablet, Oral, Once Daily~Drug: S-Amlodipine 2.5mg Tablet, Oral, Once Daily"

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01352689 - CKD-828(80/2.5mg) Pharmacokinetic Study_2nd | Biotech Hunter | Biotech Hunter